A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models.

IF 3.2 3区医学 Q2 ONCOLOGY

Clinical & Experimental Metastasis Pub Date : 2025-08-04 DOI:10.1007/s10585-025-10366-x

Wei Zhang, Samiur Rahman, Alex M L Wu, Kristine Isanogle, Christina Robinson, Dinesh Kumar, Imran Khan, Debbie Wei, Alexandra S Zimmer, Takeo Fujii, Simone Difilippantonio, Stanley Lipkowitz, Patricia Steeg

引用次数: 0

查看原文本刊更多论文

一种CSF-1R抑制剂在血液临床前模型中预防和治疗三阴性乳腺癌脑转移。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical & Experimental Metastasis 医学-肿瘤学

CiteScore

7.80

自引率

5.00%

发文量

审稿时长

12 months

期刊介绍： The Journal''s scope encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It covers such areas as molecular biology, pharmacology, tumor biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the Journal''s core subject of metastasis formation, prevention and treatment.